Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Common diabetes drug can reduce the pain of people with knee osteoarthritis and obesity

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

24 Apr 2025

DASH diet and salt reduction work together to reduce cardiovascular risk

Reducing dietary sodium and following the DASH diet each lower 10-year risk of atherosclerotic cardiovascular disease, with the greatest benefit when combined. This effect is especially strong for women, Black adults, and those with stage 2 hypertension.

23 Apr 2025

Can a plant-based diet help prevent breast cancer?

A case-control study in Iranian women found that higher adherence to a healthy plant-based diet significantly reduces breast cancer risk in postmenopausal women and those with a BMI under 25. In contrast, high intake of unhealthy plant-based foods raised risk in premenopausal women.

22 Apr 2025

New noninvasive method for early diabetes risk detection

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two.

22 Apr 2025

Diabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study finds

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of glucose-lowering drugs used in type 2 diabetes, were associated with a significantly reduced risk of Alzheimer’s disease and related dementias (ADRD). These findings suggest potential neuroprotective benefits and highlight drug repurposing as a promising strategy for ADRD prevention.

21 Apr 2025

Monell study offers renewed hope for people living with Bardet-Biedl Syndrome

A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for individuals living with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments.

18 Apr 2025

New Canadian guidelines offer comprehensive approach to managing pediatric obesity

Researchers provide evidence-based recommendations to manage pediatric obesity.

17 Apr 2025

What sauerkraut can do for your gut

Fermented cabbage metabolites play a crucial role in maintaining gut barrier function, suggesting potential health benefits for inflammatory disorders.

16 Apr 2025

New findings highlight a shifting landscape for weight loss and glucose managing medications

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

15 Apr 2025

Researchers develop drug cocktail to target enteroviruses

Enteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and much more. Over 100 different types have been described by researchers, and millions of people are infected each year.

15 Apr 2025

Digital lifestyle program cuts diabetes risk by 46% in prediabetics, study of 130k+ adults reveals

A large study of 133,764 adults found that a voluntary digital lifestyle program reduced 10-year diabetes risk by 45.6% in prediabetics and doubled remission rates in diabetics, with significant improvements in triglycerides, insulin resistance, and inflammatory markers like hs-CRP.

14 Apr 2025

Multidimensional sleep health linked to better cardiometabolic outcomes

Healthy sleep includes multiple components, such as number of hours of sleep per night, how long it takes to fall asleep, daytime functioning and self-reported sleep satisfaction, and addressing these different dimensions of sleep may help to reduce cardiometabolic health and related risk factors, according to a new American Heart Association scientific statement published today in Circulation: Cardiovascular Quality and Outcomes.

14 Apr 2025

Food pantries uncover hidden diabetes crisis in West Chicago

A screening initiative in West Chicago found that 50% of food-insecure individuals had abnormal A1c levels, with many unaware they were diabetic or prediabetic. The findings highlight a critical gap in diagnosis and control among underserved communities.

13 Apr 2025

GLP-1 agonists may reshape the gut microbiome

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory benefits for diabetes management.

11 Apr 2025

India, China, and the US will drive global diabetes burden by 2050, study finds

Global diabetes deaths and disability are rising, particularly in India, China, and the US, with type 2 diabetes (T2DM) driving the trend. Type 1 diabetes (T1DM) burdens are declining, but inequalities are widening, and projections show a steep rise in T2DM by 2050.

9 Apr 2025

WPI researcher receives NSF CAREER Award to create bioadhesives for medical applications

A Worcester Polytechnic Institute (WPI) researcher is developing a new class of medical adhesives by bringing together hydrogels and glue-like polymers to safely and reliably connect human tissues to therapeutic devices implanted in the body, such as pacemakers, insulin pumps, and artificial joints.

9 Apr 2025

Gut microbes and metabolites reveal how lifestyle changes help prevent type 2 diabetes

Researchers identified 502 blood metabolites linked to prediabetes and type 2 diabetes, with 143 tied to the gut microbiome. The study shows how lifestyle interventions like diet and exercise can modify metabolomic profiles to support glucose control.

9 Apr 2025

New molecular target identified for pancreatic cancer treatment

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology study published today.

8 Apr 2025

Genetic pathways explain why some people grow tall and others stay short

A landmark review in Nature Reviews Genetics dissects the rare and common genetic variants that shape human height. The paper explains how monogenic and polygenic factors converge on key growth pathways and influence disease risk.

7 Apr 2025

High cholesterol may not signal heart disease risk in metabolically healthy people

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across multiple institutions, has published a new study that challenges the long-held belief that high cholesterol correlates and even directly causes coronary artery disease, or plaque buildup in the arteries in metabolically healthy individuals.

7 Apr 2025

Insulin News and Research

Further Reading

Common diabetes drug can reduce the pain of people with knee osteoarthritis and obesity

DASH diet and salt reduction work together to reduce cardiovascular risk

Can a plant-based diet help prevent breast cancer?

New noninvasive method for early diabetes risk detection

Diabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study finds

Monell study offers renewed hope for people living with Bardet-Biedl Syndrome

New Canadian guidelines offer comprehensive approach to managing pediatric obesity

What sauerkraut can do for your gut

New findings highlight a shifting landscape for weight loss and glucose managing medications

Researchers develop drug cocktail to target enteroviruses

Digital lifestyle program cuts diabetes risk by 46% in prediabetics, study of 130k+ adults reveals

Multidimensional sleep health linked to better cardiometabolic outcomes

Food pantries uncover hidden diabetes crisis in West Chicago

GLP-1 agonists may reshape the gut microbiome

India, China, and the US will drive global diabetes burden by 2050, study finds

WPI researcher receives NSF CAREER Award to create bioadhesives for medical applications

Gut microbes and metabolites reveal how lifestyle changes help prevent type 2 diabetes

New molecular target identified for pancreatic cancer treatment

Genetic pathways explain why some people grow tall and others stay short

High cholesterol may not signal heart disease risk in metabolically healthy people

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News